Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva lied about opioid role, New York says | Reuters
REFILE - CORRECTING DATE Worker of Teva Pharmaceutical Industries block a road during a demonstration near the facility in Neot Hovav, southern Israel December 17, 2017. REUTERS/Amir Cohen Stock Photo - Alamy
Teva CEO exits in ongoing crisis of confidence at drugmaker
Cipla, Aurobindo Pharma acquire products divested by Teva in US | Mint
An employee of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries oversees drug production process in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the 1990s and traded
GSK's $235 million verdict revived against Teva, again | Reuters
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Pharmaceutical Industries Ltd.
Mayne Pharma Nears Deal for Teva Assets: Source
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
Teva Pharmaceutical Industries Ltd
Teva Reaches Proposed $4.35 Billion Settlement of U.S. Opioid Lawsuits
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Flags of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries are seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the
Teva buys Anda for $500 million - ISRAEL21c
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
An employee of Teva Pharmaceutical Industries stands in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva's $15B free drug opioid settlement might be a great deal in the long run: analyst | Fierce Pharma
Teva could pay $3.6b to settle opioid dispute - report - גלובס
Teva Pharmaceuticals to Lay Off 14,000 People
Teva Pharmaceutical loses another CEO, leaving investors to guess what's next | Mint